IMV INC
IMV INC
Aktie · CA44974L1031 · IMV · A2JLZ3 (XTSE)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - -5,08 % -1,62 % -99,57 %

Firmenprofil zu IMV INC Aktie

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Unternehmensdaten

Name IMV INC
Firma IMV Inc.
Symbol IMV
Website https://www.imv-inc.com
Heimatbörse XTSE TSX
WKN A2JLZ3
ISIN CA44974L1031
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Andrew Hall M.Sc.
Land Kanada
Währung CAD
Mitarbeiter 0,1 T
Adresse 130 Eileen Stubbs Avenue, B3B 2C4 Dartmouth
IPO Datum 2007-10-24

Aktien-Splits

Datum Split
13.12.2022 1:10
10.05.2018 312:1000

Ticker Symbole

Name Symbol
NASDAQ IMV

Weitere Aktien

Investoren die IMV INC die halten, haben auch folgende Aktien im Depot:
NEXITY               EO 5
NEXITY EO 5 Aktie
Shineco, Inc.
Shineco, Inc. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025